Bio News
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
Servier & Harvard Partner for Diabetes
Three year collaboration will focus on exploring a new avenue for the treatment of type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)03.21.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Domainex & SpiroChem Enter Discovery Collaboration
Domainex will enrich its existing fragment collection with a diverse set of SpiroChem fragments that it will screen with its FragmentBuilder platform03.21.19
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Preclinical Outsourcing | Process Development
WuXi STA Forms Partnership with Beta Pharma
STA will accelerate process R&D and manufacturing of late phase and commercial targets03.21.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Scale-up/Technology Transfer
VGXI Achieves Tech Transfer Milestones
Relates to RNA manufacturing partnership with research inst. in Houston03.19.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
Pall Enters Cell and Gene Therapy Mfg. Tie-up with NJII
Will invest $3.5 million in new innovation partnership03.19.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances
MilliporeSigma, GenScript to Accelerate Cell and Gene Therapy Industrialization in China
Collaboration to build global-standard platform for plasmid and virus manufacturing in China03.19.19
-
Bio News | Collaborations & Alliances | Industry News | R&D
Servier & Oncodesign Partner for Parkinson's
R&D partnership involves the LRRK2 kinase inhibitors derived from Oncodesign's proprietary Nanocyclix platform, and their potential to act against Parkinson's03.14.19
-
Bio News | Breaking News
JSR Establishes US HQ for JSR Life Sciences
Brings focus to biotech businesses including MBL, KBI Biopharma, Selexis and Crown Bioscience03.14.19
-
Bio News | Collaborations & Alliances | Formulation Development | Industry News | R&D
Rosa & Co. & Chugai Enter Research Agreement
For Rosa's PhysioPD research services, which will provide Chugai with a competitive research and development advantage across multiple therapeutic areas03.14.19
-
Bio News | Industry News | Promotions & Moves
Particle Sciences Appoints VP of Operations
Karen Bossert comes with 30 years of experience in pharmaceutical manufacturing operations, specializing in aseptic processing, lyophilization and more03.14.19
-
APIs | Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities
BioVectra to Invest $110M in Expansion Project
Prime Minister Justin Trudeau visited the CDMO to announce Government of Canada investment in the project03.14.19
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | Injectables
SunGen, Athenex Launch Busulfan Injection
Ownership transferred from Sandoz to the companies, with 2018 US Sales topping $33.6M according to IQVIA data03.14.19
-
Bio News | cGMP Manufacture | Collaborations & Alliances | Industry News
Aldevron Releases GMP-Grade SpyFi Cas9 Nuclease
Advantages of SpyFi Cas9 Nuclease include reduced off-target effects combined with clinically relevant on-target activity03.14.19
-
Bio News | Breaking News | cGMP Manufacture | Facilities
Cellectis to Build Mfg. Facility in North Carolina
With help from CMO partners, advances further towards commercialization of UCART portfolio03.12.19
-
Bio News | Breaking News | Collaborations & Alliances | R&D
AstraZeneca, Seres in Cancer Research Tie-up
Seres to receive $20 million and financial support for research activities03.12.19
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Process Validation | Scale-up/Technology Transfer
3P Enters Mfg. Tie-up With Dutch Biotech Xenikos
3P responsible for process transfer and scale-up, cGMP production for clinical trials and process validation03.12.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities
Fujifilm to Acquire Biogen Subsidiary for $890M
Biogen will enter manufacturing agreements with the CDMO to supply TYSABRI and third-party products03.12.19
-
Bio News | Industry News | Promotions & Moves
La Jolla Pharmaceutical Appoints CCO
Darryl Wellinghoff has had 19 years experience in the pharmaceutical industry including 15 years at The Medicines Company03.11.19
-
Bio News | Industry News | Packaging & Tracking | Promotions & Moves | Supply Chain
Uhlmann Appoints Regional Sales Manager
Kevin Thompson has been named regional sales manager for the South-Central United States03.11.19
-
Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News
BioPlan Benchmarks the State of Biopharma Mfg.
Participate in the 16th Annual Biopharma Survey Report!03.08.19
